SNTS, APWR, CRWE, – PennyOmega.com Stock Watch!
pennyomega Newsletter
(Mailing list information, including instructions, is located at the end of this message.)
SNTS, Santarus Inc.
SNTS , a specialty biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products for the treatment of upper gastrointestinal diseases and disorders.
SNTS and Cosmo Pharmaceuticals S.p.A. reported positive top-line results from the Phase III clinical study conducted in the U.S. and India to evaluate the safety and efficacy of budesonide MMX® for the induction of remission of mild or moderate active ulcerative colitis.
SNTS and Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals, are collaborating on the budesonide MMX Phase III clinical program.
More about SNTS at ). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
pennyomega.com
No related posts.